AEON Biopharma, Inc. (AEON) vs Aspire Biopharma Holdings, Inc. (ASBP)

AEON Biopharma, Inc. and Aspire Biopharma Holdings, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Aspire Biopharma Holdings, Inc. are of similar size ($12.7M and $12.2M). AEON Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. AEON Biopharma, Inc. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, AEON Biopharma, Inc. leads on 6 and Aspire Biopharma Holdings, Inc. on 4.

Valuation

Metric AEON ASBP Biotechnology median
P/E n/m 0.23 7.88
P/S n/m 88.39 11.47
P/B n/m 0.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m (7.59) 10.73
Earnings yield (1,700.00%) 436.88% (28.84%)
Free cash flow yield (103.87%) (83.22%) (23.03%)

Profitability

Metric AEON ASBP Biotechnology median
Gross margin — (24.97%) 65.16%
Operating margin 0.00% (7,491.61%) 0.00%
Net margin 0.00% (11,309.31%) 0.00%
Free cash flow margin 0.00% (7,355.07%) 0.00%
Return on equity 350.00% (1,032.15%) (57.72%)
Return on assets (621.70%) (152.09%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON ASBP Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (105.42%) (762.74%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AEON ASBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 7.99 4.73
Net debt to EBITDA (2.48) (0.16) 0.96

Dividend

Metric AEON ASBP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric AEON ASBP Biotechnology median
Market cap 12.65m 12.20m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack